Clinical Trials
42 trialsClinical and Molecular Characteristics of Primary Aldosteronism in Blacks
National Institutes of Health Clinical Center (CC)
Assessment of Bone Mineral Density in People Living With HIV and KSHV Associated Malignancies: A Retrospective Longitudinal Analysis
National Institutes of Health Clinical Center (CC)
REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD)
Meyer Children's Hospital IRCCS
PilatesBCS2026
Benha University
MoveStrong
University of Waterloo
REBECCA-OST
Fundación para la Investigación del Hospital Clínico de Valencia
HBHL
University of Nebraska
An Observational Study of Menopausal Symptom in Patients With Gynecological Malignancy After Oophorectomy
Anhui Provincial Hospital
Translational Development of Photon-counting CT Imaging
National Institutes of Health Clinical Center (CC)
Dried Plums Prevent Inflammation And Improve Bone Health in Osteopenic Men
Florida State University
EVOLVE
Alphatec Spine, Inc.
BLAZE
First Affiliated Hospital, Sun Yat-Sen University
Intervention Study of Drugs in Patients Osteopenia and Osteoporosis
Chinese PLA General Hospital
Investigating Bone and Skeletal Muscle Interaction in Men With Prostate Cancer
University of Texas Southwestern Medical Center
A Study of Actonel for the Prevention of Bone Loss
M.D. Anderson Cancer Center
Evaluating Radiomorphometric Indices and Fractal Dimension of the Pediatric Oncology Patients on Panoramic Images
Nuh Naci Yazgan University
Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma
National Cancer Institute (NCI)
Gene-activated Bone Substitute for Maxillofacial Bone Regeneration
Histograft Co., Ltd.
CANDLE-KIT
CANDLE-KIT Trial Study Group
Vivomixx for Prevention of Bone Loss in Women With Breast Cancer Treated With an Aromatase Inhibitor
Tel-Aviv Sourasky Medical Center
Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors and Hematopoietic Stem Cell Transplant Recipients
National Institutes of Health Clinical Center (CC)
AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast Cancer
Amgen
Study to Compare the Efficacy and Safety of DenosumAb Versus Placebo in Males With Osteoporosis
Amgen
Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients
M.D. Anderson Cancer Center
FREE Study - Fracture Reduction Evaluation
Medtronic Spinal and Biologics
REBBeCA II
University of Pittsburgh
The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy
Novartis
Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss
Amgen
Women With Cancer: An Exercise Study to Promote Health
Yale University
Pilot Study of Secondary Causes of Osteopenia/Osteoporosis in Adults With Breast and Prostate Cancer
City of Hope Medical Center
MAPLE
Brigham and Women's Hospital
Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy
Novartis
Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy
GTx
RISAROS
Hospices Civils de Lyon
Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer
Massachusetts General Hospital
Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss
M.D. Anderson Cancer Center
Study of Adults With Low Growth Hormone Who Survived Childhood Cancer Where Treatment Caused Low Bone Density
State University of New York - Upstate Medical University
Do Aromatase Inhibitors (AIs) Decrease Intestinal Calcium Absorption?
University of Wisconsin, Madison
Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer.
Novartis
SABRE
AstraZeneca
Bone Loss in Men on Androgen Blockade as Adjuvant Therapy for Prostate Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
PR.7 Companion Trial: Effect of Intermittent Versus Continuous Androgen Suppression on Bone Loss and Body Composition
Ontario Cancer Research Network